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For over 75 years, continuous manufacturing has been investigated in both academia and industry as an 
alternative to batch manufacturing. Perfusion is a well-recognized method for continuous production of 
biomolecules expressed in CHO cell culture and it is known to have certain advantages over batch and 
fed-batch processes. The major advantage of perfusion processes is that a constant environment is provided to 
cells through continuous by-product removal and nutrient addition. However, it has proven to be challenging to 
apply high-throughput approaches routinely used in fed-batch process development while maintaining true 
continuous culture, and so semi-continuous methods have instead been pursued for perfusion process 
development. In an effort to confirm how effective each method could be for early process development or as a 
quick perfusion applicability test for a particular clone, a media panel consisting of ten candidates was 
developed.  In this study, several established high-throughput small-scale models, comprising batch-refeed 
cultures in spin tubes (Corning® 50mL Mini Bioreactors) and two semi-continuous methods in ambr15™ 
microbioreactors, were applied to evaluate the performance of the perfusion media panel candidates for up to 
18 days with a recombinant CHO cell line expressing IgG. Different observations resulted from the three 
different approaches, but in each case a simulated steady-state was achieved for several key indicators such as 
cell density and product titer. Best results were seen in the spin tube batch-refeed process, where a medium 
exchange strategy of 63% per day was used to mimic metabolic by-product removal of 1 reactor volume per day 
(RVD). For the spin tube method, viable cell densities up to 30 million vc/mL were observed and the highest 
daily IgG titer of 525 mg/L (qP ~14 pg/cell/day) was achieved with perfusion medium 6 (PM6).  Additional 
verification studies to confirm these findings in small-scale perfusion bioreactors will also be discussed.  
 
